Increased Risk for Malignancies in 131 Affected CTLA4 Mutation Carriers
David Egg(University of Freiburg), Bodo Grimbacher(University Medical Center Freiburg), Charlotte Schwab(University Medical Center Freiburg), Maximilian Seidl(Heinrich Heine University Düsseldorf), Olaf Neth(Instituto de Biomedicina de Sevilla), Philippe Delvenne(University of Liège), Satoshi Okada(Rockefeller University), Klaus Warnatz(University of Freiburg), Peter D. Arkwright(University of Manchester), Michel Moutschen(University of Liège), Daniel Wolff(University Hospital Regensburg), Ann‐Christin Pecher(Center for Rheumatology), Annemarie Gabrysch(University of Freiburg), Scott B. Snapper(Massachusetts General Hospital), Catriona McLean(The Alfred Hospital), Kyoung‐Mee Kim(Samsung (South Korea)), Samar Ojaimi(Monash University), Yae‐Jean Kim, Edmund Cheesman(University of Manchester), Lisa Giulino‐Roth(Cornell University), Suranjith L. Seneviratne(Royal Free London NHS Foundation Trust), Ji‐Man Kang(Yonsei University)
Cited by 103
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
|Genome biology|2012|2.8k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k